This is a snippet of the transcript.Contact Salesto get full access.
Exactly, you got it right. Then it goes to strategic relationships and really putting together, again, what's the value proposition to the customer? What matters to them? Is it the speed of delivery? Is it the customer experience? Whatever it is, that is predicated on those strategic relationships. For example, VWR has had some pain points in the U.S. in the last year or two. We've seen it in Boston, for example. You take those two zip codes, 02138 and 02139, with MIT, Harvard, and all those medical campuses, right? There are incubators, institutes, hospital systems, and a multitude of accounts there. VWR had no sales reps for almost 12 months, so Fisher Scientific dominated for those 12 months. The business really grew, and we saw it. Their sales presence and those relationships have a long-lasting impact on these types of prime accounts.
This is a snippet of the transcript.Contact Salesto get full access.
Exactly, that's it. It's about the experience and supporting the customer in the way they need it. Offering them the right solution, however that looks. At the end of the day, they don't care if it's a 5 mL pipette packet with a specific company's logo on it. Is it Corning, Thermo Fisher, or did it come from VWR and get distributed by Fisher Scientific? They might need it, and their strategy might involve primary supply from one place and secondary from another. Whichever distributor can put it all together, reduce their tail spend, and optimize for savings and operational efficiencies, those are the things that matter. It's less about the product attributes.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.